Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0168 Transporter Info | ||||
Gene Name | SLC25A10 | ||||
Transporter Name | Mitochondrial dicarboxylate carrier | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC25A10 Modification Sites with Functional and Structural Information | |||||
Sequence |
MAAEARVSRW YFGGLASCGA ACCTHPLDLL KVHLQTQQEV KLRMTGMALR VVRTDGILAL
YSGLSASLCR QMTYSLTRFA IYETVRDRVA KGSQGPLPFH EKVLLGSVSG LAGGFVGTPA DLVNVRMQND VKLPQGQRRN YAHALDGLYR VAREEGLRRL FSGATMASSR GALVTVGQLS CYDQAKQLVL STGYLSDNIF THFVASFIAG GCATFLCQPL DVLKTRLMNS KGEYQGVFHC AVETAKLGPL AFYKGLVPAG IRLIPHTVLT FVFLEQLRKN FGIKVPS |
||||
PTM type |
X-Acetylation
X-Oxidation
X-Phosphorylation
X-S-nitrosylation
X-Succinylation
X-Ubiquitination
X: Amino Acid
|
Acetylation |
|||||
---|---|---|---|---|---|
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
132 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A10 Lysine 132 has the potential to affect its expression or activity. | ||||
Oxidation |
|||||
Cystine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [2] , [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
69 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A10 Cystine 69 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A10 | [2] , [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
181 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A10 Cystine 181 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A10 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
240 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A10 Cystine 240 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine |
4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
62 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Serine 62 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A10 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
65 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Serine 65 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A10 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
67 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Serine 67 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A10 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
93 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Serine 93 has the potential to affect its expression or activity. | ||||
Threonine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
54 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Threonine 54 has the potential to affect its expression or activity. | ||||
Tyrosine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
61 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Tyrosine 61 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A10 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
82 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Tyrosine 82 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A10 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
253 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A10 Tyrosine 253 has the potential to affect its expression or activity. | ||||
S-nitrosylation |
|||||
Cystine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [8] , [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
69 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A10 Cystine 69 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A10 | [8] , [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
181 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A10 Cystine 181 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A10 | [8] , [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
240 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A10 Cystine 240 has the potential to affect its expression or activity. | ||||
Succinylation |
|||||
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
254 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Succinylation at SLC25A10 Lysine 254 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A10 | [11] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
254 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A10 Lysine 254 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.